FAB.L Stock - Fusion Antibodies plc
Unlock GoAI Insights for FAB.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.97M | $1.14M | $2.90M | $4.80M | $4.17M |
| Gross Profit | $430,000 | $-265,000 | $202,000 | $1.72M | $1.31M |
| Gross Margin | 21.9% | -23.3% | 7.0% | 35.8% | 31.5% |
| Operating Income | $-1,779,000 | $-2,288,000 | $-2,833,000 | $-1,332,000 | $-1,379,000 |
| Net Income | $-1,713,000 | $-2,226,000 | $-2,596,000 | $-1,200,000 | $-2,899,000 |
| Net Margin | -87.2% | -196.0% | -89.5% | -25.0% | -69.6% |
| EPS | $-0.02 | $-0.04 | $-0.10 | $-0.05 | $-0.11 |
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Visit WebsiteEarnings History & Surprises
FAB.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 24, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 28, 2025 | — | — | — | — |
Q4 2024 | Nov 19, 2024 | — | $-0.01 | — | — |
Q3 2024 | Sep 5, 2024 | — | $-0.02 | — | — |
Q1 2024 | Mar 5, 2024 | — | $-0.03 | — | — |
Q3 2023 | Sep 21, 2023 | — | $-0.06 | — | — |
Q4 2022 | Dec 9, 2022 | — | $-0.04 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.02 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.02 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.09 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.02 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.01 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.02 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.02 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-0.03 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-0.03 | — | — |
Q3 2017 | Sep 30, 2017 | — | $-0.01 | — | — |
Q1 2017 | Mar 31, 2017 | — | $0.00 | — | — |
Q4 2016 | Oct 1, 2016 | — | $0.00 | — | — |
Q1 2016 | Mar 31, 2016 | — | $0.03 | — | — |
Latest News
Frequently Asked Questions about FAB.L
What is FAB.L's current stock price?
What is the analyst price target for FAB.L?
What sector is Fusion Antibodies plc in?
What is FAB.L's market cap?
Does FAB.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to FAB.L for comparison